Conexeu Sciences is trading at $2.26, down 11% now amid biotech-sector weakness; this is sector context, not a confirmed company-specific catalyst. - The sector context provided reports biotech down 2.39%; Nasdaq data showed the XBI ETF down 1.81% at 1:00 p.m. ET. - No company-specific announcement or headline for November 2 was found. The latest company releases identified in search were from October 15 and October 6.